Danaher Corp
Close on Oct 30, 2026Market cap $163.25BP/E 41.2Yield –
Danaher Biotechnology — North America: $2,418M in FY2025, up 8.1% from a year earlier.
Where the FY2025 figure comes from
Source: Danaher SEC 10-K (FY2025, filed 2026-02-24) ↗
2-dimensional revenue breakdown in Revenue Disclosures (Note 3 / Note 6, continuing operations basis following the Veralto spin-off); Q4 is calculated as Full Year (10-K) minus 9-month (10-Q Q3).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Biotechnology — North America ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2,418 | +8.1% | Danaher SEC 10-K (FY2025, filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 2,237 | -8.8% | Danaher SEC 10-K (FY2025, filed 2026-02-24) ↗ |
| FY2023 | Dec 31, 2023 | 2,454 | -19.6% | Danaher SEC 10-K (FY2025, filed 2026-02-24) ↗ |
| FY2022 | Dec 31, 2022 | 3,054 | +5.3% | Danaher SEC 10-K (FY2024, filed 2025-02-20) ↗ |
| FY2021 | Dec 31, 2021 | 2,899 | – | Danaher SEC 10-K (FY2023, filed 2024-02-21) ↗ |
Cite this data
StockData. (2026). Danaher Biotechnology — North America ($M), annual FY2021–FY2025 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/disagg-biotech-geo-na
See every metric in the Danaher KPI table. Data updated Nov 2, 2026.